Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
Immunohorizons|November 11, 2020
RAB11FIP5-Deficient Mice Exhibit Cytokine-Related Transcriptomic SignaturesDapeng Li, Todd Bradley, Derek W Cain, et al.Plos One|June 18, 2016
Genetic Characterization of a Panel of Diverse HIV-1 Isolates at Seven International SitesBhavna Hora, Sheila M Keating, Yue Chen, et al.Frontiers in Immunology|January 10, 2022
Polyclonal Broadly Neutralizing Antibody Activity Characterized by CD4 Binding Site and V3-Glycan Antibodies in a Subset of HIV-1 Virus ControllersTinashe E Nyanhete, Robert J Edwards, Celia C LaBranche, et al.Cell|October 2, 2018
RAB11FIP5 Expression and Altered Natural Killer Cell Function Are Associated with Induction of HIV Broadly Neutralizing Antibody ResponsesTodd Bradley, Dimitra Peppa, Isabela Pedroza-Pacheco, et al.Virology|September 12, 2009
Cross-reactive monoclonal antibodies to multiple HIV-1 subtype and SIVcpz envelope glycoproteinsFeng Gao, Richard M Scearce, S Munir Alam, et al.Retrovirology|November 1, 2012
Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genomeHongshuo Song, Jeffrey W Pavlicek, Fangping Cai, et al.Cell Reports|March 16, 2023
Neonatal SHIV infection in rhesus macaques elicited heterologous HIV-1-neutralizing antibodiesBhavna Hora, Hui Li, Xiaoying Shen, et al.Nature Communications|May 17, 2018
Tracking HIV-1 recombination to resolve its contribution to HIV-1 evolution in natural infectionHongshuo Song, Elena E Giorgi, Vitaly V Ganusov, et al.Plos Pathogens|June 14, 2012
Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin α4β7Nicholas F Parrish, Craig B Wilen, Lauren B Banks, et al.Proceedings of the National Academy of Sciences of the United States of America|April 2, 2013
Phenotypic properties of transmitted founder HIV-1Nicholas F Parrish, Feng Gao, Hui Li, et al.Pageof 4